Status of vaccine research and development of vaccines for GBS
about
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesEvaluation of procedures for typing of group B Streptococcus: a retrospective study.Immunization During Pregnancy: Impact on the Infant.Strategies to develop vaccines of pediatric interest.Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.Codevelopment of Microbiota and Innate Immunity and the Risk for Group B Streptococcal Disease.Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.Late Onset Streptococcus agalactiae Meningitis following Early Onset Septicemia: A Preventable Disease?Clinical and laboratory features of Group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001-2014.Diminished capsule exacerbates virulence, blood brain barrier penetration, intracellular persistence and antibiotic evasion of hyperhemolytic Group B Streptococcus.Status of group B streptococcal vaccine development.Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.Screening for group B Streptococcus (GBS) at labour onset using PCR: accuracy and potential impact - a pilot study.Management of group b streptococcus-positive pregnant women at maternity homes in JAPAN: a questionnaire survey of compliance among midwives.Potential targets for next generation anti-microbial glycoconjugate vaccines.Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years.Global etiology of bacterial meningitis: A systematic review and meta-analysis.Perinatal Streptococcus agalactiae Epidemiology and Surveillance TargetsEpitopes of Immunoreactive Proteins of : Enolase, Inosine 5'-Monophosphate Dehydrogenase and Molecular Chaperone GroEL
P2860
Q28075884-472ED09A-7473-4456-93D2-378F19226CA0Q37710063-526C484A-B163-446C-8184-7ED2527B9829Q38683189-C40C669D-CB4F-4CB0-910C-8DC9B86F8AE4Q38819027-AD537054-9D6E-4D64-89E9-1655B1E20536Q39386700-C4440486-5B17-4E89-BA02-23E2A2F99B45Q40091166-180F215D-7B9A-44D6-9685-C289C1D38DD5Q40344808-DB235820-B902-44C0-994D-60403A9A42CBQ45934269-0E1ABC1D-1367-48D2-92D4-9DFA50ECE77CQ46247272-596B2450-A1F4-4894-B107-7E87DBBEA840Q46954965-8DF07018-3A9A-4381-A974-50C3A949E137Q46987999-F27349ED-2C6E-4B38-BC1F-9A342E27015AQ47134871-B4E36BF7-1CFF-42A2-A05A-F34236DF8FDDQ47767787-F7E22FC9-2C17-4301-BC5E-CA1B691CB3D5Q47883436-00772653-5602-4F5A-81AC-B3B06F4798A2Q48041915-367831E3-4A1B-44AA-94EC-BC1C19167F31Q48053443-706EAEA5-2D87-4F24-A7B7-C3073921A1C4Q48310970-ED5BF8A4-E62E-40B7-B77F-16A51B067074Q49677528-FA539B39-FCB0-47D7-8FAE-0D777330B4D0Q53701548-1E74AD9E-A87D-4D58-9AE3-BB61129B3D32Q55012752-E71A137C-B9F6-4E3E-90DB-504549C0F390Q55224904-5FC06149-CD8C-46D2-8D29-CE686D0AA7A8Q57169196-7544C1D8-FBEF-46AF-B82E-608D2579F273Q58586144-C2482D56-A8D8-459C-AEDC-694ED7EA7FD8
P2860
Status of vaccine research and development of vaccines for GBS
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Status of vaccine research and development of vaccines for GBS
@ast
Status of vaccine research and development of vaccines for GBS
@en
type
label
Status of vaccine research and development of vaccines for GBS
@ast
Status of vaccine research and development of vaccines for GBS
@en
prefLabel
Status of vaccine research and development of vaccines for GBS
@ast
Status of vaccine research and development of vaccines for GBS
@en
P3181
P1433
P1476
Status of vaccine research and development of vaccines for GBS
@en
P2093
Paul T. Heath
P304
P3181
P356
10.1016/J.VACCINE.2015.12.072
P407
P50
P577
2016-03-15T00:00:00Z